CR Pharma sets price range for $2bn HK IPO
China Resources Pharmaceutical Group will raise as much as HK$15.6bn ($2.0bn) via a Hong Kong IPO after firming up the price range.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: